7-(Benzyloxy)-5-methoxy-2-(4-methoxyphenyl)-4H-chromen-4-one, 98%, 1g

N,N-DIMETHYL-3-(1H-PYRAZOL-4-YL)PROP-2-YN-1-AMINE, 95.0%, 1g

3-Acetyl-5-chlorothiophene-2-boronic acid, 98+%, 5g

1-(tert-Butoxycarbonyl)-4-(ethoxycarbonyl)piperidine-4-carboxylic acid, 97%, 5g

Methyl 2-mercaptobenzo[d]oxazole-6-carboxylate, 95.0%, 10g

Propargyl acetate, 97.0%, 1g

3-(4-Chloro-benzyl)-pyridine, 25g

1-Adamantyl(3-amino-1-benzofuran-2-yl)methanone, 95.0%, 1g

4-[(tert-butoxycarbonyl)amino]-1-methylpiperidine-4-carboxylic acid, 500mg

N-Metilmorfolina, mínimo 98,5 %, para síntesis, 2,5 l, envase de vidrio

H-Phe-NH2 HCl, 95%, 25g

2-Chloro-6-(1H-pyrazol-1-yl)pyrazine, 95.0%, 100g

1-Chloro-4-(prop-1-en-2-yl)benzene, 95.0%, 5g